Henrik Zetterberg
1 – 10 of 50
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
- CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression : A study of fully automated immunoassays in BioFINDER and ADNI cohorts
- Association of cerebral amyloid-β Aggregation with cognitive functioning in persons without dementia
- Investigating the genetic architecture of dementia with Lewy bodies : a two-stage genome-wide association study
- 2017
- 18F-AV-1451 and CSF T-tau and P-tau as biomarkers in Alzheimer's disease
- CSF/serum albumin ratio in dementias : a cross-sectional study on 1861 patients
- Genome-wide, high-content siRNA screening identifies the Alzheimer’s genetic risk factor FERMT2 as a major modulator of APP metabolism
- Effects of surgery and propofol-remifentanil total intravenous anesthesia on cerebrospinal fluid biomarkers of inflammation, Alzheimer's disease, and neuronal injury in humans : A cohort study
- Consensus guidelines for lumbar puncture in patients with neurological diseases
- Ex vivo 18O-labeling mass spectrometry identifies a peripheral amyloid β clearance pathway
- Cerebrospinal Fluid Stanniocalcin-1 as a Biomarker for Alzheimer's Disease and Other Neurodegenerative Disorders